Biotek PowerWave - Page 21

xvii
Number of Kinetic Points Selection............................................. 3-15
Onset OD Selection..................................................................... 3-15
Well Scanning ............................................................................. 3-16
Map Definition................................................................................................ 3-17
Map Generation...........................................................................3-18
Mapping Direction ....................................................................... 3-19
Replication Direction ................................................................... 3-19
Start Mapping at Well Location ................................................... 3-22
Blank Map Selection.................................................................... 3-22
Constant Blank Value.................................................................. 3-24
Number of Blanks........................................................................ 3-25
Blank Location............................................................................. 3-25
Number of Standards.................................................................. 3-26
Number of Standard Replicates .................................................. 3-26
Average Standards...................................................................... 3-27
Standard Concentration .............................................................. 3-27
Reuse of Standard Curves.......................................................... 3-28
Number of Controls..................................................................... 3-30
Type of Control............................................................................ 3-31
Number of Control Replicates ..................................................... 3-31
Location of Controls .................................................................... 3-32
Number of Samples..................................................................... 3-32
Number of Sample Replicates..................................................... 3-33
Sample Location..........................................................................3-33
Panel........................................................................................... 3-35
Formula Definition......................................................................................... 3-40
Formula Type.............................................................................. 3-41
Validation Type Selection............................................................ 3-41